1. Skip to navigation
  2. Skip to content
  3. Skip to sidebar

Products

Keep up to date with the latest UHERO products.

The Impact of Stronger Property Rights in Pharmaceuticals on Innovation in Developed and Developing Countries

Posted March 14, 2014 | Categories: UHERO Working Papers, LaCroix, Sumner

We use dynamic panel data regressions to investigate whether the strength of a country’s patent protection for pharmaceuticals is associated with more pharmaceutical patenting by its residents and corporations in the United States. Using the Pharmaceutical Intellectual Property Protection (PIPP) Index to measure patent strength, we run dynamic probit and Poisson regressions on panels from 25 developing and 41 developed countries over the 1970-2004 period. Results vary, depending on whether we examine partial effects at the mean or average partial effects for the PIPP Index. APEs for the PIPP Index are positive but statistically insignificant in both developed and developing country samples.

WORKING PAPER


« view all products